To our surprise, all BP-CML patients showed wild-type FLT3 sequences, and none of the recurrent FLT3 mutations were detected in our cohort (Fig. 6K, S6L). Here, FLT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.